| Goodwill and Intangible Assets, Net |
Goodwill and Intangible Assets, Net The Company tests goodwill at least annually for possible impairment. The Company completes the annual testing of impairment for goodwill on the later of November 1 or the first day of its eleventh fiscal month of each fiscal year. In addition to its annual test, the Company regularly evaluates whether events or circumstances have occurred that may indicate a potential impairment of goodwill. The process of testing goodwill for impairment involves the determination of the fair value of the applicable reporting units. The test consists of the comparison of the fair value to the carrying value of the reporting unit to determine if the carrying value exceeds the fair value. If the carrying value of the reporting unit exceeds its fair value, an impairment loss in an amount equal to that excess is recognized up to the amount of goodwill. The changes in the carrying amount of goodwill for the three months ended April 5, 2026 were as follows: | | | | | | | | | | | | | | | | | | | Life Sciences | | Diagnostics | | Consolidated | | | (In thousands) | | Balance at December 28, 2025 | $ | 4,744,962 | | | $ | 1,868,531 | | | $ | 6,613,493 | | | Foreign currency translation | (24,952) | | | (9,826) | | | (34,778) | | | Acquisitions | 32,035 | | | — | | | 32,035 | | | Balance at April 5, 2026 | $ | 4,752,045 | | | $ | 1,858,705 | | | $ | 6,610,750 | |
Identifiable intangible asset balances by category were as follows: | | | | | | | | | | | | | April 5, 2026 | | December 28, 2025 | | | (In thousands) | | Patents | $ | 27,592 | | | $ | 27,592 | | | Less: Accumulated amortization | (26,579) | | | (26,524) | | | Net patents | 1,013 | | | 1,068 | | | Trade names and trademarks | 148,996 | | | 150,103 | | | Less: Accumulated amortization | (103,298) | | | (102,234) | | | Net trade names and trademarks | 45,698 | | | 47,869 | | | Licenses | 27,550 | | | 27,561 | | | Less: Accumulated amortization | (20,214) | | | (19,849) | | | Net licenses | 7,336 | | | 7,712 | | | Core technology | 1,641,071 | | | 1,624,925 | | | Less: Accumulated amortization | (945,967) | | | (921,325) | | | Net core technology | 695,104 | | | 703,600 | | | Customer relationships | 2,886,388 | | | 2,870,384 | | | Less: Accumulated amortization | (1,329,005) | | | (1,283,630) | | | Net customer relationships | 1,557,383 | | | 1,586,754 | | | | | | | Total | $ | 2,306,534 | | | $ | 2,347,003 | | | | | | | | | | | | | |
Total amortization expense related to amortizable intangible assets was $85.1 million and $82.7 million for the three months ended April 5, 2026 and March 30, 2025, respectively. Estimated amortization expense related to amortizable intangible assets is $254.5 million for the remainder of fiscal year 2026, $312.7 million for fiscal year 2027, $286.8 million for fiscal year 2028, $256.7 million for fiscal year 2029, and $227.9 million for fiscal year 2030
|